Your browser doesn't support javascript.
loading
Genomic Status of MET Potentiates Sensitivity to MET and MEK Inhibition in NF1-Related Malignant Peripheral Nerve Sheath Tumors.
Peacock, Jacqueline D; Pridgeon, Matthew G; Tovar, Elizabeth A; Essenburg, Curt J; Bowman, Megan; Madaj, Zachary; Koeman, Julie; Boguslawski, Elissa A; Grit, Jamie; Dodd, Rebecca D; Khachaturov, Vadim; Cardona, Diana M; Chen, Mark; Kirsch, David G; Maina, Flavio; Dono, Rosanna; Winn, Mary E; Graveel, Carrie R; Steensma, Matthew R.
Afiliação
  • Peacock JD; Center for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids, Michigan.
  • Pridgeon MG; College of Health Professions, Ferris State University, Big Rapids, Michigan.
  • Tovar EA; Spectrum Health System, Helen DeVos Children's Hospital, Grand Rapids, Michigan.
  • Essenburg CJ; Center for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids, Michigan.
  • Bowman M; Center for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids, Michigan.
  • Madaj Z; Bioinformatics and Biostatistics Core, Van Andel Research Institute, Grand Rapids, Michigan.
  • Koeman J; Bioinformatics and Biostatistics Core, Van Andel Research Institute, Grand Rapids, Michigan.
  • Boguslawski EA; Genomics Core, Van Andel Research Institute, Grand Rapids, Michigan.
  • Grit J; Center for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids, Michigan.
  • Dodd RD; Center for Cancer and Cell Biology, Van Andel Research Institute, Grand Rapids, Michigan.
  • Khachaturov V; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
  • Cardona DM; Spectrum Health System, Helen DeVos Children's Hospital, Grand Rapids, Michigan.
  • Chen M; Department of Pathology, Duke University Medical Center, Durham, North Carolina.
  • Kirsch DG; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
  • Maina F; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
  • Dono R; Department Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina.
  • Winn ME; Aix-Marseille Univ, CNRS, IBDM, Marseille, France.
  • Graveel CR; Aix-Marseille Univ, CNRS, IBDM, Marseille, France.
  • Steensma MR; Bioinformatics and Biostatistics Core, Van Andel Research Institute, Grand Rapids, Michigan.
Cancer Res ; 78(13): 3672-3687, 2018 07 01.
Article em En | MEDLINE | ID: mdl-29720369
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Neurofibromatose 1 / Proteínas Proto-Oncogênicas c-met / Inibidores de Proteínas Quinases Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Neurofibromatose 1 / Proteínas Proto-Oncogênicas c-met / Inibidores de Proteínas Quinases Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article